Paper37463569
Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy.
Ruiz C and 13 others. Pathobiology, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy. Papers, record 37463569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37463569
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Long Noncoding | Major topic |
| Prostatic Neoplasms | Major topic |
| Male | |
| Humans | |
| Prostate | |
| Prostate-Specific Antigen | |
| Prostatectomy | |
| Neoplasm Recurrence, Local | |
| Neoplasm Grading |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34370973 | Prostate cancer. | Lancet | 2021 | https://conductscience.org/library/papers/34370973 | PubMed |
| 2 | 29035381 | High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models. | Lab Invest | 2018 | https://conductscience.org/library/papers/29035381 | PubMed |
| 3 | 16963728 | Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16963728 | PubMed |
| 4 | 32566661 | Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32566661 | PubMed |
| 5 | 23659877 | Early detection of prostate cancer: AUA Guideline. | J Urol | 2013 | https://conductscience.org/library/papers/23659877 | PubMed |
| 6 | 26332453 | DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. | Prostate | 2015 | https://conductscience.org/library/papers/26332453 | PubMed |
| 7 | 32141110 | Quality of life in active surveillance for early prostate cancer. | Int J Urol | 2020 | https://conductscience.org/library/papers/32141110 | PubMed |
| 8 | 23770138 | Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. | J Urol | 2013 | https://conductscience.org/library/papers/23770138 | PubMed |
| 9 | 17264329 | Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17264329 | PubMed |
| 10 | 31445843 | The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. | Eur Urol | 2019 | https://conductscience.org/library/papers/31445843 | PubMed |
| 11 | 32869873 | Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex. | Hepatology | 2021 | https://conductscience.org/library/papers/32869873 | PubMed |
| 12 | 24475196 | Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer. | PLoS One | 2014 | https://conductscience.org/library/papers/24475196 | PubMed |
| 13 | 17532856 | Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer. | BJU Int | 2007 | https://conductscience.org/library/papers/17532856 | PubMed |
| 14 | 35219000 | LINC00624/TEX10/NF-κB axis promotes proliferation and migration of human prostate cancer cells. | Biochem Biophys Res Commun | 2022 | https://conductscience.org/library/papers/35219000 | PubMed |
| 15 | 31411988 | Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy. | Eur Urol Oncol | 2019 | https://conductscience.org/library/papers/31411988 | PubMed |
| 16 | 35370981 | Connecting the Dots Between the Gut-IGF-1-Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35370981 | PubMed |
| 17 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 18 | 21176740 | Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR. | Int J Clin Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21176740 | PubMed |
| 19 | 32459716 | The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. | Am J Surg Pathol | 2020 | https://conductscience.org/library/papers/32459716 | PubMed |
| 20 | 29029453 | PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort. | Oncotarget | 2017 | https://conductscience.org/library/papers/29029453 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40136513 | Uncovering New Biomarkers for Prostate Cancer Through Proteomic and Network Analysis. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40136513 | PubMed |
| 39803655 | Blockade of neutral sphingomyelinase 2 exerts antitumor effect on metastatic castration resistant prostate cancer cells and promotes tumor regression when combined with Enzalutamide. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39803655 | PubMed |
| 39161338 | Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX. | Oncol Lett | 2024 | https://conductscience.org/library/papers/39161338 | PubMed |
| 38757383 | Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review). | Oncol Rep | 2024 | https://conductscience.org/library/papers/38757383 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37463569
GET https://conductscience.org/api/papers/v1/37463569/references?page=2